Truvestments Capital’s Northrop Grumman NOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$21.4K Sell
42
-17
-29% -$9.81K ﹤0.01% 670
2026
Q1
$40.3K Buy
59
+32
+119% +$22.1K 0.01% 529
2025
Q4
$15.4K Buy
27
+16
+145% +$9.29K ﹤0.01% 631
2025
Q3
$6.7K Sell
11
-53
-83% -$30.1K ﹤0.01% 770
2025
Q2
$32K Buy
64
+50
+357% +$24.6K 0.01% 471
2025
Q1
$7.17K Sell
14
-3
-18% -$1.43K ﹤0.01% 706
2024
Q4
$7.98K Buy
17
+3
+21% +$1.51K ﹤0.01% 639
2024
Q3
$7.39K Buy
+14
New +$6.86K ﹤0.01% 622
2022
Q1
– Sell
-20
Closed -$8K – 410
2021
Q4
$8K Hold
20
– – ﹤0.01% 425
2021
Q3
$7K Hold
20
– – ﹤0.01% 422
2021
Q2
$7K Buy
+20
New +$7.2K ﹤0.01% 428
2020
Q3
– Sell
-6
Closed -$1K – 467
2020
Q2
$1K Buy
+6
New +$1.97K ﹤0.01% 545
2019
Q4
– Sell
-75
Closed -$28K – 428
2019
Q3
$28K Hold
75
– – 0.02% 357
2019
Q2
$24K Sell
75
-30
-29% -$8.94K 0.02% 392
2019
Q1
$28K Buy
+105
New +$28.6K 0.02% 352
2018
Q3
$34K Buy
+107
New +$32.6K 0.02% 442

Other funds holding NOC

Truvestments Capital's NOC Position: Q2 2026 in Review

Truvestments Capital reduced its Northrop Grumman (NOC) stake by 29% in Q2 2026, selling an estimated $9.81K and leaving 42 shares worth $21.4K. The position accounts for ﹤0.01% of the portfolio, ranked #670.

Truvestments Capital first reported a position in NOC in Q3 2018 and has held it in 16 quarters since. The position peaked at $40.3K in Q1 2026. 1,817 funds tracked by Wall St. Rank hold NOC as of Q2 2026.

  • Truvestments Capital held 42 shares of Northrop Grumman worth $21.4K as of Q2 2026.
  • Truvestments Capital sold 17 Northrop Grumman shares in Q2 2026, an estimated $9.81K.
  • Northrop Grumman made up ﹤0.01% of Truvestments Capital's portfolio in Q2 2026, its #670 holding.
  • Truvestments Capital first reported a position in Northrop Grumman in Q3 2018 and has held it in 16 quarters since.
  • Truvestments Capital's Northrop Grumman position peaked at $40.3K in Q1 2026.
  • 1,817 funds tracked by Wall St. Rank held Northrop Grumman as of Q2 2026.

Based on Truvestments Capital's 13F filing for Q2 2026, filed 12 Aug 2026.